T 0349/15 of 12.11.2019
- European Case Law Identifier
- ECLI:EP:BA:2019:T034915.20191112
- Date of decision
- 12 November 2019
- Case number
- T 0349/15
- Petition for review of
- -
- Application number
- 07764495.3
- IPC class
- A61P 25/24A61P 25/28A61P 25/18A61P 25/32A61P 25/34A61P 25/36A61P 25/22C07D 295/08A61K 31/495
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- 1-[2-(2,4-DIMETHYLPHENYLSULFANYL)-PHENYL]PIPERAZINE AS A COMPOUND WITH COMBINED SEROTONIN REUPTAKE, 5-HT3 AND 5-HT1A ACTIVITY FOR THE TREATMENT OF COGNITIVE IMPAIRMENT
- Applicant name
- H. Lundbeck A/S
- Opponent name
- Sandoz AG
- Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- -
- Keywords
- -
- Catchword
- -
- Cited cases
- G 0003/14
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent in amended form on the basis of claims 1 to 16 of the main request filed as "AR1" during the oral proceedings before the board, and a description to be adapted thereto.